Literature DB >> 30676328

Acute-on-chronic liver failure: management and prognosis.

Jody C Olson1.   

Abstract

PURPOSE OF REVIEW: Hospitalizations due to complications of cirrhosis continue to rise. Patients with chronic liver disease who suffer acute decompensation [acute-on-chronic liver failure (ACLF)] often require intensive care support and are at high risk for short-term mortality. Given the high mortality rate associated with this condition is incumbent on intensive care providers who care for this patient population to have a working knowledge of ACLF with its associated complications, management strategies and prognosis. RECENT
FINDINGS: Recognizing ACLF as a distinct clinical entity has gained international attention in recent years though a consensus does not exist. There has been progress on better defining this clinical entity and recent studies have begun to address the critical care needs of these patients. Additional studies are required to define the best care practices for patients with ACLF.
SUMMARY: ACLF is a condition occurring in patients with chronic liver disease which is commonly associated with a need for intensive care support and carries a high risk of short-term mortality. Intensive care specialists must be familiar with diagnosis and management of this condition.

Entities:  

Mesh:

Year:  2019        PMID: 30676328     DOI: 10.1097/MCC.0000000000000595

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  2 in total

1.  Long Non-coding RNA NEAT1 Alleviates Acute-on-Chronic Liver Failure Through Blocking TRAF6 Mediated Inflammatory Response.

Authors:  Yumin Xu; Zhujun Cao; Yezhou Ding; Ziqiang Li; Xiaogang Xiang; Rongtao Lai; Zike Sheng; Yuhan Liu; Wei Cai; Ronggui Hu; Hui Wang; Qing Xie
Journal:  Front Physiol       Date:  2019-12-12       Impact factor: 4.566

2.  Serum Nitric Oxide Level Serves as a Potential Prognostic Biomarker in ACLF Patients.

Authors:  Fei Wang; Minghui Tai; Yajuan He; Zhen Tian
Journal:  Int J Gen Med       Date:  2022-08-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.